Soluble HLA class I and class II antigens in patients with multiple sclerosis

Tissue Antigens

Volumn 51, Issue 3, 1998, Pages 301-304

  Ott, M ^a   Stecker, K ^e   Seidl, C ^b   Seifried, E ^b   Westhoff, U ^c,d   Grosse Wilde, H ^c   Fischer, P A ^e  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

^b Inst Transfusionsmedizin I   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d Fachklinik Hornbeide   (Germany)

^e GOETHE UNIVERSITY   (Germany)

Author keywords

Multiple sclerosis; Soluble HLA antigen

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; STEROID;

ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOSTIMULATION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; SERUM;

EID: 0343917452     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb03106.x     Document Type: Article

References (22)

1. Traugott U. Multiple sclerosis: relevance of class I and class II MHC expressing cells to lesion development. J Neuroimmunol 1987: 16: 283-302.
2. Hafler DA, Hemler ME, Christenson L et al. Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseases. Clin Immunol Immunpathol 1985: 37: 163-171.
3. Tiwary JL, Terasaki PI, Neurology, multiple sclerosis. In: HLA and disease association. New York: Springer Verlag, 1985: 152-167.
4. Haines JL, Ter-Minassian M, Bazyk A et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. The Multiple Sclerosis Genetics Group. Nat Genet 1996: 13: 469-471.
5. Krangel MS. Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med 1986: 163: 1173-1190.
6. Briata P, Radka SF, Sartoris S, Lee JS. Alternative splicing of HLA-DQ beta transcripts and secretion of HLA-DQ beta proteins: allelic polymorphism in splicing and polyadenylation sites. Proc Natl Acad Sa U S A 1989: 86: 1003-1007.
7. Zavazava N, Hausmann R, Mueller-Ruchholtz W. Inhibition of anti-HLA B7 alloreactive CTL by affinity purified soluble HLA. Transplantation 1991: 51: 838-842.
8. Hofmann GW, Kion TA, Grant MD. An idiotypic network model of AIDS immunopathogenesis. Proc Natl Acad Sci U S A 1991: 88: 3060-3064.
9. Blasczyk R, Westhoff U, Grosse-Wilde H. Soluble CD4, CD8 and HLA molecules in commercial immunoglobulin preparations. Lancet 1993: 341: 789-790.
10. Zavazava N, Krönke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med 1996: 9: 1005-1010.
11. Alvarez-Cermeno JC, Villar LM, Nocito M, Bootello A, Gonzalez-Proque P. Intrathecal synthesis of soluble class I antigens in multiple sclerosis. J Neuroimmunol 1992: 36: 77-79.
12. Alvarez-Cermeno JC, Brieva JA, Villar LM, Roldan E, Bootello A, Gonzalez-Proque P. Soluble Class I antigen secretion by peripheral blood lymphocytes in multiple sclerosis. Eur Neurol 1993: 33: 229-231.
13. Poser CM, Paty DW, Scheinberg L, McDonald I, Davis FA. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983: 13: 227-231.
14. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983: 33: 1444-1452.
15. Westhoff U, Grosse-Wilde H. Soluble HLA class I and class II concentrations in factor VIII and PCC preparations. Vox Sang 1995: 68: 73-76.
16. Pouletty P, Ferrone S, Amesland F et al. Summary report from the first international workshop on soluble HLA antigens. Paris, August 1992. Tissue Antigens 1993: 42: 45-54.
17. Ziegler A, Heinig J, Müller C et al. Analysis by sequential immunoprecipitations of the specificities of the monoclonal antibodies TÜ22, 34, 35, 36, 37, 39, 43, 58 and YD1/63.HLK directed against human HLA class II antigens, Immunobiology 1986: 171: 77-92.
18. Ghosh AK, Gatter KC, Mason DY. Immunocytochemical characterisation of monoclonal anti HLA-DR antibodies. In: Steel CM, ed. Disease markers. Sussex: John Wiley & Sons, 1984: 223-233.
19. Thinnes FP, Egert G, Götz H et al. Primärstruktur der menschlichen Histokompatibilitätsantigene der Klasse II (HLA-D). Isolierung, Reinigung und Charakterisierung des A/B-Ketten-Komplexes einer homozygoten, lymphoblastoiden B-Zell-Linie, H2LCL (HLA-A3,3; B7,7; Dw2,w2; DR2,2; MT1,1; DC1,1; MB1,1). Hoope-Seylers Z Physiol Chern 1984: 365: 1277-1289.
20. Westhoff U, Thinnes FP, Götz H, Grosse-Wilde H.Quantitation of soluble HLA class II molecules by an enzyme-linked immunosorbent assay. Vox Sang 1991: 61: 106-110.
21. Selmaj K, Raine CS, Furooq M, Norton WT, Brosnum CF. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol 1991: 147: 1522-1529.
22. Rieckmann P, Albrecht M, Kitze B et al. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 1994: 44: 1523-1526.